Compare Fastenal Company Common Stock (FAST) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fastenal Company Common Stock vs Hinge Health Inc. Class A Common Stock — how do they compare? Fastenal Company Common Stock trades at $52.45 (market cap $59.02B), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B). The key difference: Fastenal Company Common Stock is far larger — about 7× Hinge Health Inc. Class A Common Stock's market cap, and Fastenal Company Common Stock pays a 1.87% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fastenal Company Common Stock for 2 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| FAST | HNGE | |
|---|---|---|
Market Cap | $59.02B | $8.48B |
Volume | 10,054,911 | 879,799 |
Sector | Industrials | Health |
52-Week High | $52.38 | $105.14 |
52-Week Low | $39.15 | $31.17 |
Typical Hold Time | 2 Days | 0 Days |
Enterprise Value | $59.25B | $8.10B |
Dividend Yield | 1.87% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Fastenal (FAST) trades at $51.43, down 0.12% on the day, with strong technical momentum indicated by bullish moving averages. The company demonstrates robust fundamentals with Q3 2026 earnings of $0.35 per share beating estimates, marking the fourth consecutive quarterly beat. Revenue grew 15.5% year-over-year to $2.46 billion, driven by market share gains and new contract wins. The stock shows resilience with consistent operational performance despite premium valuation metrics.
Outlook remains positive with strong industrial demand and digital initiatives supporting growth, though the elevated P/E ratio of 43.96 presents valuation risk. Analyst consensus leans cautious with 59% hold ratings, suggesting limited near-term upside from current levels. Key risks include economic sensitivity and competitive pressures in industrial distribution.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fastenal Company Common Stock
Fastenal distributes fasteners, tools, safety supplies, and other industrial products. It also provides inventory management and vending solutions for business customers.
Read more on FAST →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
